PROMETH W Drug Patent Profile
✉ Email this page to a colleague
When do Prometh W patents expire, and when can generic versions of Prometh W launch?
Prometh W is a drug marketed by G And W Labs Inc and is included in one NDA.
The generic ingredient in PROMETH W is dextromethorphan hydrobromide; promethazine hydrochloride. There are twenty-three drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the dextromethorphan hydrobromide; promethazine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROMETH W?
- What are the global sales for PROMETH W?
- What is Average Wholesale Price for PROMETH W?
Summary for PROMETH W
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | PROMETH W at DailyMed |
US Patents and Regulatory Information for PROMETH W
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G And W Labs Inc | PROMETH W/ DEXTROMETHORPHAN | dextromethorphan hydrobromide; promethazine hydrochloride | SYRUP;ORAL | 088762-001 | Oct 31, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
